Abstract
Background: The purpose of this study was to examine the influence of preoperative marijuana use on postoperative opioid use during the first three postoperative days (POD 1-3) after surgery, and on expectations of pain control, resiliency, and quality-of-life scores.
Methods: All patients presenting to a single institution undergoing elective hand or upper extremity outpatient surgery were asked to complete pre- and postoperative questionnaires. Preoperative questionnaires collected information on demographics, marijuana use, tobacco use, procedure type, self-assessed health, pain control expectations, and EuroQol-5D (EQ-5D) scores. At the first postoperative visit, patients self-reported opioid consumption from POD 1-3. Multivariate linear regression analysis was used to determine which patient characteristics were predictive of greater postoperative opioid consumption during POD 1-3.
Results: Self-reported marijuana users were younger, less healthy, and more likely to use tobacco compared to non-users. Marijuana users and non-users were comparable in their use of pain medication (including non-opioids), rates of chronic pain diagnoses, and self-reported pain tolerance. EQ-5D scores were lower in marijuana users than non-users (0.64 vs. 0.72). Marijuana users and non-users were prescribed comparable quantities of opioids during the first 14 days after surgery (176 ± 148 vs 115 ± 87). Multiple linear regression analysis revealed that lower preoperative EQ-5D scores, rather than marijuana use, were associated with increased opioid consumption during POD 1-3.
Conclusions: Preoperative marijuana use was not independently associated with increased opioid use during POD 1-3 after elective hand and upper extremity surgery; instead, an association with lower preoperative EQ-5D scores was identified.
Level of evidence: II, prospective cohort study.
Keywords: Cannabinoid, EQ-5D, Marijuana, Narcotics, Pain management
© 2022. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.
References
-
- Kazmers NH, Stephens AR, Tyser AR (2019) Effects of baseline opioid medication use on patient-reported functional and psychological impairment among hand clinic patients. J Hand Surg Am 44:829–839. https://doi.org/10.1016/j.jhsa.2019.07.003 – DOI – PubMed
-
- Carnevale JT, Kagan R, Murphy PJ, Esrick J (2017) A practical framework for regulating for-profit recreational marijuana in US States: lessons from Colorado and Washington. Int J Drug Policy 42:71–85. https://doi.org/10.1016/j.drugpo.2017.03.001 – DOI – PubMed
-
- Martins SS, Segura LE, Levy NS et al (2021) Racial and ethnic differences in cannabis use following legalization in us states with medical cannabis laws. JAMA Netw Open 4:e2127002–e2127002. https://doi.org/10.1001/JAMANETWORKOPEN.2021.27002 – DOI – PubMed – PMC
-
- Caldera FE (2020) Medical cannibus as an alternative for opioids for chronic pain: a case report. SAGE Open Med Case Reports 8:2050313X2090701. https://doi.org/10.1177/2050313×20907015 – DOI
-
- Ashton CH (2001) Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 178:101–106 – DOI

